BIORUS is proud to announce its upcoming product launch event for Diasorin-Luminex products, taking place on February 28th 2023, in Dubai. At this event, leading experts in the healthcare industry will be present to discuss the clinical significance of HSV 1&2 as molecular testing and the clinical significance of GI testing.
Dr. Katherine Moore from the National Health Service (NHS) will be the guest speaker at this event, providing insight into the clinical significance of these two tests. She will also be discussing the importance of these tests in the diagnosis of infectious diseases and their clinical implications.
The event will be attended by key opinion leaders (KOLs) from the UAE, who will have the opportunity to gain first-hand experience of the new Diasorin-Luminex products. The event will include presentations and demonstrations of the products, as well as the opportunity to interact with experts in the field.
BIORUS is dedicated to the development of innovative products that help improve healthcare quality and patient outcomes. The Diasorin-Luminex products are designed to provide accurate, reliable and cost-effective solutions for the diagnosis of infectious diseases. The product launch event is a great opportunity for KOLs to learn more about how these products can help improve healthcare in the UAE.
We look forward to welcoming you to the event and providing you with an unforgettable experience. Your presence will help foster a better understanding of the clinical significance of HSV 1&2 and GI testing, and the impact that these tests can have on healthcare quality and patient outcomes.